Recombinant Mouse XCR1 Protein，His

XCR1, or X-C motif chemokine receptor 1, is a crucial receptor involved in the immune system's response to pathogens and cancer. It is primarily expressed on a subset of dendritic cells known as cross-presenting dendritic cells, which are essential for the activation of CD8+ T cells. Research on XCR1 has gained momentum due to its role in mediating immune responses and its potential implications in immunotherapy and vaccine development. As a chemokine receptor, XCR1 participates in the migration of dendritic cells to lymphoid tissues, enhancing the presentation of antigens derived from extracellular sources. This unique pathway is vital for the generation of cytotoxic T cell responses, particularly against tumors and viral infections. Recombinant XCR1 protein studies aim to elucidate the structural and functional aspects of this receptor, aiding the understanding of its signaling mechanisms and interactions with ligands. Furthermore, characterizing XCR1 through recombinant technologies has implications for developing targeted therapies that can boost immune responses or harness XCR1's function in treating malignancies. The ongoing research not only helps in advancing fundamental immunology but also paves the way for novel therapeutic approaches that could improve the efficacy of current cancer treatments and vaccines.